Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
about
Adjuvant chemotherapy for advanced endometrial cancerEmotional and sexual concerns in women undergoing pelvic surgery and associated treatment for gynecologic cancerClinicopathological Significance and Potential Drug Target of CDKN2A/p16 in Endometrial CarcinomaTelmisartan induces growth inhibition, DNA double-strand breaks and apoptosis in human endometrial cancer cellsSALL4 as an Epithelial-Mesenchymal Transition and Drug Resistance Inducer through the Regulation of c-Myc in Endometrial CancerStereotactic radiosurgery for brain metastasis from gynecological malignanciesSHARP1 suppresses angiogenesis of endometrial cancer by decreasing hypoxia-inducible factor-1α levelUse of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer TherapyIntegrated microRNA and mRNA transcriptome sequencing reveals the potential roles of miRNAs in stage I endometrioid endometrial carcinomaUpregulation of TrkB promotes epithelial-mesenchymal transition and anoikis resistance in endometrial carcinoma.Parity Correlates with the Timing of Developing Endometrial Cancer, But Not Subtype of Endometrial Cancer.Long non-coding RNA derived miR-205-5p modulates human endometrial cancer by targeting PTEN.Survival and Control Prognosticators of Recurrent Gynecological Malignancies of the Pelvis and Para-aortic Region Treated with Stereotactic Body Radiation Therapy.Neo-adjuvant chemotherapy for advanced stage endometrial carcinoma: a glimmer of hope in select patients.MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.MiR-106a promotes tumor growth, migration, and invasion by targeting BCL2L11 in human endometrial adenocarcinoma.Development of an Image-Guided Orthotopic Xenograft Mouse Model of Endometrial Cancer with Controllable Estrogen Exposure
P2860
Q24194639-BDFC7BC2-A265-411E-8505-5750A29F039FQ26773707-DFC96AC0-A6E9-491C-9A19-0ABC6CABA4BFQ26797456-1368BE17-B2B5-4BD1-8CB4-5C42C41D062EQ28541515-3DF47631-0F1B-49CC-AF69-33927304AD46Q28548494-91E37A77-0AFB-4B85-A06F-FFD1691785FBQ33598798-F4AEFFC3-B0B6-4308-8964-153D9356A0D2Q33740510-9BAC2DA7-318C-4BD2-89D9-69ECA057D251Q33859472-EAB80E59-7A3A-4B34-90EC-509A456E1CB5Q34362064-94C99D73-2C7B-43E8-9892-5570A94D146CQ34923263-4DA03015-2DAE-4639-8301-9C3B0D8BCAE3Q36190111-CC436D8F-E10E-4054-B1B4-D136FE71CF5DQ36420288-702E6BDD-10A8-40BB-9210-B769B1EF9E73Q37427531-BED59A59-625D-4071-A2CB-84B0F5B55D99Q38569619-0BFFDE57-6DA3-4574-901A-54FC47CF3BFFQ38715510-B6A6467E-8C2C-4B4B-B1AF-A9FDCF94AC0BQ47098747-08E798DD-F732-4475-95F2-9D83F7256BA7Q58697190-71191392-B531-4A05-B067-9D3BCBF5377A
P2860
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
@ast
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
@en
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
@en-gb
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
@nl
type
label
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
@ast
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
@en
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
@en-gb
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
@nl
prefLabel
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
@ast
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
@en
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
@en-gb
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
@nl
P2093
P2860
P1476
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
@en
P2093
Claire L Vale
Paul R Symonds
Sarah J Bull
P2860
P356
10.1002/14651858.CD003915.PUB4
P577
2012-08-15T00:00:00Z